Stockreport

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF IPH6501 is a first-in-class tetra-specific NK cell engager armed with a variant of IL-2, targeting CD20 and developed for B-NHLIPH6501 boosts NK cell proliferation and c [Read more]